Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Dovato maker?

See the DrugPatentWatch profile for Dovato

Dovato is manufactured by ViiV Healthcare [1][2][3]. ViiV Healthcare is a global specialist HIV company established in 2009 by GlaxoSmithKline (GSK) and Pfizer, with Shionogi joining in 2012 [4].

What is Dovato used for?


Dovato is a prescription medication used to treat HIV-1 infection in adults and children weighing at least 88 pounds (40 kg) [5]. It is intended for patients who have not previously been treated for HIV or for those who are switching from another HIV medication to a new treatment regimen [5][6]. The medication works by reducing the amount of HIV in the body, helping to improve the immune system [5].

How does Dovato work?


Dovato is a combination antiretroviral medication that contains two active ingredients: dolutegravir and lamivudine [5][6]. Dolutegravir is an integrase inhibitor, and lamivudine is a nucleoside analog reverse transcriptase inhibitor [6]. Together, these drugs interfere with the replication cycle of the human immunodeficiency virus (HIV), preventing it from multiplying and spreading throughout the body [5][6].

When does Dovato's patent expire?


Patent expiry dates for medications can be complex, involving multiple patents that cover different aspects of the drug, such as the compound itself, its formulation, or its method of use. Information on specific patent expiry dates for Dovato can be found through patent tracking services like DrugPatentWatch.com [7]. These services provide detailed insights into patent landscapes, including expiration timelines, which are crucial for understanding when generic versions might become available [7].

Who are Dovato's competitors?


Dovato competes in the HIV treatment market with a range of other antiretroviral therapies. Many other pharmaceutical companies offer single-tablet regimens and combination therapies for HIV. The competitive landscape is dynamic, with ongoing research and development for new treatments and improved formulations [8].

What are the common side effects of Dovato?


Common side effects reported with Dovato include insomnia, headache, nausea, diarrhea, fatigue, and dizziness [5][6]. Serious side effects can also occur, such as liver problems, lactic acidosis, and hypersensitivity reactions. Patients are advised to report any new or worsening symptoms to their healthcare provider [5].



Other Questions About Dovato :

dovato 日本 dovato 50/300 what’s the price difference between viiv healthcare’s dovato and gilead’s biktarvy? Is there a generic for dovato? Dovato vs biktarvy weight gain? Is Dovato a two-drug HIV regimen? How does Dovato work as a two-drug regimen?